NCCN Prostate Cancer Low Risk Group

**Semantic type:** Intellectual Product

**Definition:** A prostate cancer risk group characterized by: clinical stage T1-T2a, biopsy Gleason score of 6 or less, and PSA level less than 10 ng/mL.

**Synonyms:** - Low Risk Group